MALAT1 and non-small cell lung carcinoma: In a mouse model of metastatic NSCLC, subcutaneous injection of MALAT1 ASO significantly reduced the burden of lung nodules, indicating the therapeutic potential of targeting MALAT1 in metastatic lung cancer130, 131.